Literature DB >> 11345384

Smoking cessation in heart failure: it is never too late.

J Lightwood, K E Fleischmann, S A Glantz.   

Abstract

Entities:  

Mesh：

Year:  2001        PMID： 11345384     DOI： 10.1016/s0735-1097(01)01188-3

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN： 0735-1097            Impact factor:   24.094


× No keyword cloud information.
  8 in total

1.  Smoking cessation and Alzheimer's disease: facts, fallacies and promise.

Authors:  Janine K Cataldo; Stanton A Glantz
Journal:  Expert Rev Neurother       Date:  2010-05       Impact factor: 4.618

Review 2.  The US Public Health Service "treating tobacco use and dependence clinical practice guidelines" as a legal standard of care.

Authors:  Randy M Torrijos; Stanton A Glantz
Journal:  Tob Control       Date:  2006-12       Impact factor: 7.552

3.  Effects of smoking in patients treated with cardiac resynchronization therapy.

Authors:  Laura Perrotta; Brunilda Xhaferi; Marco Chiostri; Paolo Pieragnoli; Giuseppe Ricciardi; Luigi Di Biase; Andrea Natale; Ilaria Ricceri; Mazda Biria; Dhanunjay Lakkireddy; Alessandro Valleggi; Michele Emdin; Federica Michelotti; Giosuè Mascioli; Angela Pandozi; Massimo Santini; Luigi Padeletti
Journal:  Intern Emerg Med       Date:  2012-12-19       Impact factor: 3.397

4.  Influence of Cigarette Smoking on Burden and Characteristics of Coronary Artery Plaques in Chinese Men.

Authors:  Yujiao Sun; Xin Yu; Ying Zhi; Song Geng; Hua Li; Ting Liu; Ke Xu; Guoxian Qi
Journal:  Acta Cardiol Sin       Date:  2015-09       Impact factor: 2.672

5.  National Rate of Tobacco and Substance Use Disorders Among Hospitalized Heart Failure Patients.

Authors:  Sarah C Snow; Gregg C Fonarow; Joseph A Ladapo; Donna L Washington; Katherine J Hoggatt; Boback Ziaeian
Journal:  Am J Med       Date:  2018-12-16       Impact factor: 4.965

6.  Effectiveness of telemedicine and distance learning applications for patients with chronic heart failure. A protocol for prospective parallel group non-randomised open label study.

Authors:  Giedrius Vanagas; Jelena Umbrasiene; Rimvydas Slapikas
Journal:  BMJ Open       Date:  2012-09-25       Impact factor: 2.692

Review 7.  Dark nights behind the white clouds - risks of tobacco smoking on human health besides the oral health and malignancy.

Authors:  Zarin Zainul
Journal:  EXCLI J       Date:  2011-05-12       Impact factor: 4.068

8.  Low apolipoprotein A-I levels in Friedreich's ataxia and in frataxin-deficient cells: Implications for therapy.

Authors:  QingQing Wang; Lili Guo; Cassandra J Strawser; Lauren A Hauser; Wei-Ting Hwang; Nathaniel W Snyder; David R Lynch; Clementina Mesaros; Ian A Blair
Journal:  PLoS One       Date:  2018-02-15       Impact factor: 3.240
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.